Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GW-493838

Copy Product Info
😃Good
Catalog No. T27509Cas No. 253124-46-8
Alias GW-493838X, GW493838X, GW493838, GW 493838X, GW 493838

GW-493838 is a potent adenosine A1A receptor agonist for the treatment of dyslipidemia and neuropathic pain, with analgesic effects on post-herpetic neuralgia or peripheral nerve damage caused by trauma or surgery.

GW-493838

GW-493838

Copy Product Info
😃Good
Purity: 99.58%
Catalog No. T27509Alias GW-493838X, GW493838X, GW493838, GW 493838X, GW 493838Cas No. 253124-46-8
GW-493838 is a potent adenosine A1A receptor agonist for the treatment of dyslipidemia and neuropathic pain, with analgesic effects on post-herpetic neuralgia or peripheral nerve damage caused by trauma or surgery.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$154In StockIn Stock
5 mg$385In StockIn Stock
10 mg$547In StockIn Stock
25 mg$822In StockIn Stock
50 mg$1,110In StockIn Stock
100 mg$1,500In StockIn Stock
500 mg$2,940-In Stock
1 mL x 10 mM (in DMSO)$443In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.58%
ee:100%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
GW-493838 is a potent adenosine A1A receptor agonist for the treatment of dyslipidemia and neuropathic pain, with analgesic effects on post-herpetic neuralgia or peripheral nerve damage caused by trauma or surgery.
SynonymsGW-493838X, GW493838X, GW493838, GW 493838X, GW 493838
Chemical Properties
Molecular Weight489.89
FormulaC21H21ClFN7O4
Cas No.253124-46-8
SmilesO[C@H]1[C@H](N2C=3C(N=C2)=C(NC4=C(F)C=C(Cl)C=C4)N=CN3)O[C@@H]([C@H]1O)C=5OC(C(C)(C)C)=NN5
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 11 mg/mL (22.45 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0413 mL10.2064 mL20.4127 mL102.0637 mL
5 mM0.4083 mL2.0413 mL4.0825 mL20.4127 mL
10 mM0.2041 mL1.0206 mL2.0413 mL10.2064 mL
20 mM0.1021 mL0.5103 mL1.0206 mL5.1032 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GW-493838 | purchase GW-493838 | GW-493838 cost | order GW-493838 | GW-493838 chemical structure | GW-493838 formula | GW-493838 molecular weight